mRNA-4157/V940in combination with Keytruda receives PRIME scheme designation from EMA

Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma

Bridgewest Group launches new sterile injectable CDMO NovaCina

Philips and Northwell Health partner to standardize patient monitoring across the enterprise

New York State’s largest health system adopts Philips patient monitoring platform to drive integration and innovation for a better patient and staff experience and improved outcomes

Dozee Raises $6 million to bolster its ambition of ‘HarBedDozeeBed’

Dozee plans to further tap over 2,000 hospitals in more than 100 districts

Israeli researchers develop an effective drug to prevent muscle diseases

The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.

FDA approves Merck’s Keytruda in combination with Padcev for treatment of metastatic urothelial cancer

First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patients

Hutchmed completes rolling submission of NDA to USFDA for fruquintinib

NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China

Getinge to boost scalability and deepen healthcare access in India

Getinge has a strong market share in India within several product segments

Evonik starts construction of US$220 million lipid innovation center in Lafayette

Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness

Heartfulness signs hits a new milestone by signing an MoU with AIIMS